ArticleMolecular therapy : the journal of the American Society of Gene Therapy2026
Restricting efferocytosis pathway to CD91 via phosphatidylserine-targeting chimeric protein augments antitumor immune responses.
Yu Mizote et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.